08:33 AM EST, 02/03/2025 (MT Newswires) -- Baxter International's ( BAX ) former kidney care segment Vantive said Monday it has been acquired by funds managed by Carlyle Group ( CG ) .

Vantive will now operate as an independent organ therapy company, it added.

The deal was first announced by Baxter and Carlyle in August, under which Carlyle agreed to acquire Vantive for $3.8 billion.

Baxter shares were down 2.3% in recent Monday premarket activity, while Carlyle slipped 3%.